SCHEMBL14082683

SCHEMBL14082683

O=C(Nc1ccc(Cl)cc1Cl)c1ccc(-c2cc(C(F)(F)F)ccn2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 3/20 0.56
▸ KDM4E B2RXH2 1/20 0.56
▸ NPSR1 Q6W5P4 1/20 0.56
▸ RAB9A P51151 2/20 0.51
▸ CYP1A2 P05177 1/20 0.51
▸ CYP2D6 P10635 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ HDAC1 Q13547 2/20 0.48
▸ TRPV1 Q8NER1 2/20 0.48
▸ PPARG P37231 2/20 0.47
▸ PPARD Q03181 2/20 0.47
▸ NR1H4 Q96RI1 2/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ POLB P06746 1/20 0.47
▸ THRB P10828 1/20 0.46
▸ MEN1 O00255 2/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ ALDH1A1 P00352 1/20 0.45
▸ KDM1A O60341 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14252981 0.94 TRPV1 (0.51) RXFP1KDM4ENPSR1RAB9ACYP1A2
SCHEMBL14082678 0.88 TRPV1 (0.55) RXFP1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL14082689 0.83 MEN1 (0.56) RXFP1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL14082429 0.83 RXFP1 (0.60) RXFP1KDM4ENPSR1RAB9ACYP1A2
SCHEMBL14082672 0.82 TRPV1 (0.57) RXFP1RAB9ATRPV1PPARGPPARD
SCHEMBL14082710 0.82 RAB9A (0.58) RXFP1KDM4ERAB9AHDAC1TRPV1
SCHEMBL14082233 0.80 KDM4E (0.70) RXFP1KDM4ENPSR1RAB9ATRPV1
SCHEMBL14082701 0.80 NPC1 (0.53) KDM4ENPSR1RAB9AHDAC1TRPV1
SCHEMBL14082708 0.80 SORT1 (0.59) KDM4ENPSR1HDAC1TRPV1POLB
SCHEMBL14082688 0.80 TRPV1 (0.73) RAB9AHDAC1TRPV1NPC1KDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 RXFP1 1053/4885KDM4E 4231/4885NPSR1 406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback